TRANSCENTA-B(06628) issued 451,500 shares of incentive stock and 22,500 stock options.
Chuangsheng Group Medicine-B (06628) announced that on June 30, 2026, the company granted 451,500 shares of incentive shares to 136 award grantees and granted 22,500 stock options to 9 stock option grantees under the stock incentive plan.
TRANSCENTA-B (06628) announced that on June 30, 2026, the company granted a total of 451,500 shares of incentive shares to 136 incentive recipients and granted 22,500 stock options to 9 option recipients under the share incentive plan.
Related Articles
COSCO SHIPPING Development(02866) plans to invest 8.656 billion yuan to acquire a total of 24 vessels.
REALWAY CAPITAL(01835): Change of controlling shareholder, offering a cash offer of approximately 39.39% discount and will resume trading on July 2nd.
HUNLICAR GROUP (03638) announced its annual performance, with a net profit attributable to shareholders of HK$28.166 million.
COSCO SHIPPING Development(02866) plans to invest 8.656 billion yuan to acquire a total of 24 vessels.
REALWAY CAPITAL(01835): Change of controlling shareholder, offering a cash offer of approximately 39.39% discount and will resume trading on July 2nd.
HUNLICAR GROUP (03638) announced its annual performance, with a net profit attributable to shareholders of HK$28.166 million.
RECOMMEND
